LCT to sell JV shares for $3 million and receive Diabecell licence
In: Global Data Point, 2018-01-27
Zeitungsartikel
Zugriff:
New Zealand-based Living Cell Technologies (ASX: LCT) has agreed to sell its 50% shareholding in joint venture company, Diatranz Otsuka Limited (DOL), to the other 50% shareholder, Japans Otsuka Pharmaceutical [...]
Titel: |
LCT to sell JV shares for $3 million and receive Diabecell licence
|
---|---|
Zeitschrift: | Global Data Point, 2018-01-27 |
Veröffentlichung: | 2018 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|